Policy & Medicine - Legal, Regulatory, and Compliance Issues

Those of us in the continuing medical education (CME) community have seen a growing movement over the past several years to…

In 2010, the Department of Veterans Affairs ("VA") proposed a regulation that would impose limits on the promotion of drug and…

Earlier this month, the Food and Drug Administration (FDA) released a new Clinical Trials Guidance Document.  The guidance…

As we have covered numerous times on this blog, in 2009, the State of Massachusetts enacted the Massachusetts Pharmaceutical and…

The Europeans are now joining the chorus for principled relationships with industry.  The European Society of Cardiology…

There have been significant media coverage and government oversight surrounding drug shortages over the past few months.  On…

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced an expansion of its Code of…

Now that the comment period for the Physician Payment Sunshine Act (Section 6002 of the Affordable Care Act) has closed, various…

Mid-February marked the deadline for stakeholders to submit their comments on the proposed regulations from the Centers for…

Dr. Henry Black, a Clinical Professor of Internal Medicine at the New York University School of Medicine, recently gave a…